Format

Send to

Choose Destination
BMC Cardiovasc Disord. 2016 Jan 19;16:16. doi: 10.1186/s12872-016-0192-8.

Semaphorin 3A attenuates cardiac autonomic disorders and reduces inducible ventricular arrhythmias in rats with experimental myocardial infarction.

Author information

1
Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, 250014, Jinan, China. hyperhhs@163.com.
2
Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, 250014, Jinan, China. 57467238@qq.com.
3
Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, 250014, Jinan, China. xuemei2575@126.com.
4
Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, 250014, Jinan, China. chengwenjuan12@163.com.
5
Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, 250014, Jinan, China. yeziwang812@163.com.
6
Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, 250014, Jinan, China. xinran0207@126.com.
7
Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, 250014, Jinan, China. yjangelsmile@126.com.
8
Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, 250014, Jinan, China. lixiaolu006@163.com.
9
Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, 250014, Jinan, China. emilynana.hi@163.com.
10
Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, 250014, Jinan, China. 497972404@qq.com.
11
Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, 250014, Jinan, China. yansuhua5537@163.com.

Abstract

BACKGROUND:

To investigate the effects of semaphorin 3A (sema 3A) on cardiac autonomic regulation and subsequent ventricular arrhythmias (VAs) in post-infarcted hearts.

METHOD AND RESULTS:

In order to explore the functions of sema 3A in post-infarcted hearts, lentivirus-Sema 3A-shRNA and negative control vectors were delivered to the peri-infarcted myocardium rats respectively. Meanwhile, recombinant sema 3A and control (0.9% NaCl solution) were injected intravenously into infarcted rats to test the therapeutic potential of sema 3A. Results indicated that levels of sema 3A were higher in post-infarcted hearts compared with sham rats. However, sema 3A silencing leaded to sympathetic hyperinnervation, increased myocardial norepinephrine (NE) content and inducible VAs. Conversely, the intravenous administration of sema 3A to infarcted rats reduced sympathetic nerve sprouting, improved cardiac autonomic regulation, and decreased the incidence of inducible VAs. However, both infarct size and cardiac function were similar among infarcted hearts.

CONCLUSIONS:

The upregulation and administration of sema 3A exerted beneficial effects on infarction-induced cardiac autonomic disorders by increasing cardiac electrical stability and reducing VAs. Sema 3A might be a potential therapeutic agent for cardiac autonomic abnormalities induced arrhythmias.

PMID:
26787044
PMCID:
PMC4719212
DOI:
10.1186/s12872-016-0192-8
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center